Cargando…
Alpha-1 antitrypsin deficiency and risk of lung cancer in never-smokers: a multicentre case–control study
BACKGROUND: Lung cancer (LC) is the most commonly diagnosed cancer and the leading cause of cancer-related death in both sexes worldwide. Although the principal risk factor in the western world is tobacco smoking, genetic factors, including alpha-1 antitrypsin deficiency (AATD), have been associated...
Autores principales: | Tubío-Pérez, Ramón Antonio, Torres-Durán, María, García-Rodríguez, María Esmeralda, Candal-Pedreira, Cristina, Rey-Brandariz, Julia, Pérez-Ríos, Mónica, Barros-Dios, Juan, Fernández-Villar, Alberto, Ruano-Raviña, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767679/ https://www.ncbi.nlm.nih.gov/pubmed/35045822 http://dx.doi.org/10.1186/s12885-022-09190-3 |
Ejemplares similares
-
Is lung cancer in never smokers still an unknown disease?
por: Candal-Pedreira, Cristina, et al.
Publicado: (2022) -
Alpha-1 antitrypsin deficiency and risk of lung cancer: A systematic review
por: Tubío-Pérez, Ramón A., et al.
Publicado: (2020) -
Risk factors for chronic obstructive pulmonary disease in never‐smokers: A systematic review
por: Pando‐Sandoval, Ana, et al.
Publicado: (2022) -
Small-cell lung cancer in never-smokers
por: Torres-Durán, M., et al.
Publicado: (2021) -
Polymorphisms in the BER and NER pathways and their influence on survival and toxicity in never-smokers with lung cancer
por: Casal-Mouriño, Ana, et al.
Publicado: (2020)